Target intelligence / Profile preview

RNA, U6 small nuclear 704, pseudogene (RNU6-704P)

Target
RNU6-704P
Molecular classification
Other (pseudogene), Non-coding RNA (snRNA pseudogene family)
01

Overview

RNU6-704P refers to a pseudogene derived from the gene encoding U6 small nuclear RNA, one of the five main snRNAs found in the spliceosome complex responsible for excising introns from nuclear pre-mRNA in eukaryotes[3]. Pseudogenes are genomic elements that resemble functional genes but are typically noncoding due to sequence disruption, mutation, or lack of regulatory elements. The parent molecule, U6 snRNA, is highly conserved and essential for splicing, participating directly in the catalytic core of the spliceosome and facilitating splice site recognition and catalysis[1][3]. In contrast, U6 snRNA pseudogenes like RNU6-704P generally lack biological activity and are believed to be evolutionary remnants or byproducts of gene duplication/transposition events[5][2]. While some pseudogenes have regulatory roles—acting as competitive endogenous RNAs, antisense regulators, or epigenetic modifiers—the majority do not encode functional products, and there is no published evidence for a biological, clinical, or therapeutic function for RNU6-704P in human disease or physiology[4][2]. It is not considered a therapeutic target, and erroneous listing as a target would be incorrect according to current literature and gene databases[2][4].

Other names
RNU6-704PRNA, U6 small nuclear 704, pseudogene
02

Mechanism of action

Null (no drugs or molecules target this pseudogene)

03

Biological functions

None (as a pseudogene, not known to have canonical biological functions; the parental U6 snRNA functions in pre-mRNA splicing[1][3], but pseudogenes typically do not yield functional products)
04

Disease associations

Other (pseudogenes can act as competing endogenous RNAs or have regulatory functions, but there are no data that RNU6-704P specifically has a disease role[4])Null (no direct evidence for involvement in cancer, inflammation, neurodegeneration, etc.)
05

Safety considerations

Null (not a therapeutic target; no safety concerns reported)
06

Interacting drugs

Null (no known drugs interact with this pseudogene)
07

Biomarkers

Null (not known as a biomarker for patient selection or monitoring)

Beyond the preview

Go deeper on RNA, U6 small nuclear 704, pseudogene (RNU6-704P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 704, pseudogene (RNU6-704P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call